Phil Revenue and Competitors
Estimated Revenue & Valuation
- Phil's estimated annual revenue is currently $29M per year.
- Phil received $10.0M in venture funding in August 2017.
- Phil's estimated revenue per employee is $150,500
- Phil's total funding is $121.6M.
Employee Data
- Phil has 193 Employees.
- Phil grew their employee count by 12% last year.
Phil's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Staff to CEO | Reveal Email/Phone |
2 | Head Business Operations and Strategic Finance | Reveal Email/Phone |
3 | VP Client Success | Reveal Email/Phone |
4 | VP Business Development | Reveal Email/Phone |
5 | Head Design | Reveal Email/Phone |
6 | VP Business Development | Reveal Email/Phone |
7 | VP, Controller | Reveal Email/Phone |
8 | VP, Operations | Reveal Email/Phone |
9 | VP, Patient Experience | Reveal Email/Phone |
10 | VP Marketing | Reveal Email/Phone |
Phil Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $212.8M | 1063 | 5% | $65M | N/A |
#2 | $35.6M | 231 | 6% | N/A | N/A |
#3 | $45M | 299 | -4% | $102.6M | N/A |
#4 | $3.2M | 30 | -25% | $21.3M | N/A |
#5 | $34M | 226 | 0% | $42.9M | N/A |
#6 | $3.6M | 34 | -28% | $35M | N/A |
#7 | $0.8M | 10 | N/A | N/A | N/A |
#8 | $12.6M | 90 | -9% | N/A | N/A |
#9 | $17.4M | 124 | 0% | $96.4M | N/A |
#10 | $5.2M | 49 | -25% | $75.6M | N/A |
What Is Phil?
Phil is a service that matches folks taking recurring medications with top-rated, community-based pharmacies that manage and deliver prescriptions on time, at no extra cost and take on the task of navigating doctors and insurance.
keywords:Healthcare, Health Care Information Technology$121.6M
Total Funding
193
Number of Employees
$29M
Revenue (est)
12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Phil News
Phil Jones has been included in Man United's starting lineup for their clash with Liverpool. United have made the trip to Merseyside on...
Manchester United made four changes for the Liverpool game with Phil Jones handed a rare start.
The defender was handed just his second start of the season at Anfield following a formation change to a five-man defence by German boss...
SAN FRANCISCO, Sept. 29, 2021 /PRNewswire/ -- Phil, Inc. announces partnership with Impel NeuroPharma, Inc. (NASDAQ: IMPL) in support of Trudhesa™ (dihydroergotamine mesylate) nasal spray (0.725 mg per spray) to provide technology-powered patient support and distribution services through Phil's ...
Phil, a San Francisco, CA-based provider of therapy deployment software for the pharma market, raised $56M in Series D funding. The round is part of an arrangement for Warburg Pincus to invest up to $100 million. As part of the deal, Fred Hassan, Director at Warburg Pincus, will join Phil’s boa ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $73.2M | 193 | 2% | $40M |
#2 | $29.7M | 193 | N/A | N/A |
#3 | $53.9M | 193 | 4% | N/A |
#4 | $63.3M | 193 | 30% | $213.5M |
#5 | $7.5M | 193 | 65% | N/A |
Phil Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2017-08-17 | $10.0M | Undisclosed | Crosslink Capital | Article |